Johnson & Johnson subsidiary McNeil PPC has agreed to pay 42 states $33 million to settle claims that it distributed contaminated over-the-counter drugs and unlawfully promoted those products, including a $1.04 million payment to New Jersey.
The settlement, announced Wednesday, was the product of an investigation led by the Pennsylvania and Texas Offices of Attorney General. New Jersey was one of 10 states in an executive committee handling the matter, according to a release from the New Jersey Attorney General’s Office.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
